Epilepsy, Complex Partial - 14 Studies Found

Completed : Bioavailability, Safety, and Tolerability of BIS-001 ER
: Epilepsy, Complex Partial
: 2017-05-15
: Drug: BIS-001 ER BIS-001 ER is an extended release formulation of the nutritional supplement Huperzine A
Completed : A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601
: Epilepsy, Complex Partial
: 2009-10-16
: Drug: ganaxolone liquid suspension, 50 mg/mL, up to 500 mg/day TID or 1500 mg/day, up to 1 year
Completed : Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy
: Epilepsy, Complex Partial
: 2003-03-18
: Drug: Zonisamide
Completed : Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin
: Epilepsy, Complex Partial
: 2010-05-20
:
  • Drug: Pregabalin 150 mg /day
Completed : Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism
:
  • Epilepsy
  • Epilepsy, Complex Partial

: 1999-11-03
Completed : Pregabalin Open-Label Extension Trial in Patients With Partial Seizures
:
  • Epilepsies, Partial
  • Epilepsy, Complex Partial

: 2005-08-30
: Drug: Pregabalin
Completed : An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.
:
  • Epilepsy
  • Complex Partial Seizures
  • Ep
    : 2009-10-06
    : Drug: carisbamate Open-Label Extension: 400 mg/day (up to a maximum of 1200mg/day) given in 2 equally di
Completed : An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures
:
  • Epilepsy, Partial, Motor
  • Epilepsy, Complex Partial
  • : 2008-08-29
    :
    • Drug: placebo placebo for 1 we
Completed : A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.
:
  • Epilepsy, Partial, Motor
  • Epilepsy, Complex Partial
  • : 2008-08-21
    :
    • Drug: Carisbamate 800 mg/day f
Completed : A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.
:
  • Epilepsy
  • Epilepsy, Focal
  • Seizure Disorder